Holdings

DAFNA Capital Management LLC

As of Sep 30, 2026, DAFNA Capital Management LLC reported 77 positions worth US$446M. Largest: Revolution Medicines, Inc., AtriCure, Inc. and COMPASS Pathways Plc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Revolution Medicines, Inc.487KUS$100M−75,500Sep 30, 2026
AtriCure, Inc.523KUS$29.4M−74,684Sep 30, 2026
COMPASS Pathways Plc2.14MUS$26.6MnewSep 30, 2026
State Street SPDR S&P Biotech ETF152KUS$23.9MnewSep 30, 2026
Nektar Therapeutics323KUS$19.6M+5,000Sep 30, 2026
IDEAYA Biosciences, Inc.439KUS$16.9M−58,500Sep 30, 2026
Stereotaxis, Inc.13.7MUS$16.8Mno changeSep 30, 2026
Denali Therapeutics Inc.744KUS$15.4M+5,000Sep 30, 2026
Arcus Biosciences, Inc.440KUS$11.4M−2,000Sep 30, 2026
Cytokinetics, Incorporated172KUS$11.3Mno changeSep 30, 2026